Skip to main content
Year archive

MAYNE PHARMA GROUP LIMITED — 2014 filings

All 41 regulatory filings released by MAYNE PHARMA GROUP LIMITED (MYX) in 2014, sourced directly from the official regulator.

41 Filings
2014 Period
2014 filings (41)
Filing Released Lang
Appendix 3B 10 pages 549.5KB
Share Issue/Capital Change
2014-12-21 English
Change of Director's Interest Notice 2 pages 127.5KB
Director's Dealing
2014-12-21 English
Change of Director's Interest Notice 2 pages 129.1KB
Director's Dealing
2014-12-17 English
Appendix 3B 9 pages 355.7KB
Share Issue/Capital Change
2014-12-04 English
Change of Director's Interest Notice 2 pages 127.3KB
Director's Dealing
2014-12-04 English
Change in substantial holding from WBC 11 pages 352.6KB
Major Shareholding Notification
2014-11-30 English
Change in substantial holding from BTT 12 pages 175.9KB
Major Shareholding Notification
2014-11-30 English
2014 AGM Chairman's Speech 4 pages 239.6KB
AGM Information
2014-11-26 English
2014 AGM CEO's Speech 7 pages 305.5KB
AGM Information
2014-11-26 English
Results of Meeting 3 pages 406.7KB
Declaration of Voting Results & Voting Rights Announcements
2014-11-26 English
Mayne Pharma announces US Paragraph IV Challenge 2 pages 245.9KB
Legal Proceedings Report
2014-11-17 English
Appendix 3B 9 pages 272.6KB
Capital/Financing Update
2014-10-29 English
Notice of Annual General Meeting/Proxy Form 10 pages 621.3KB
AGM Information
2014-10-26 English
Change of Director's Interest Notice 3 pages 429.1KB
Director's Dealing
2014-10-06 English
Initial Director's Interest Notice 2 pages 69.6KB
Director's Dealing
2014-09-29 English
Appendix 3B 9 pages 271.8KB
Share Issue/Capital Change
2014-09-09 English
Change in substantial holding from WBC 15 pages 347.9KB
Major Shareholding Notification
2014-09-04 English
Change in substantial holding from BTT 16 pages 227.6KB
Major Shareholding Notification
2014-09-04 English
2014 Appendix 4E & Annual Report 84 pages 2.9MB
Annual Report
2014-08-26 English
2014 Full Year Results Media Release 6 pages 248.2KB
Annual Report
2014-08-26 English
2014 Full Year Results Investor Presentation 20 pages 1.5MB
Earnings Release
2014-08-26 English
2014 Corporate Governance Statement 15 pages 601.5KB
Governance Information
2014-08-26 English
Mayne Pharma appoints new Board member 1 page 215.2
Board/Management Information
2014-08-25 English
Mayne Pharma appoints Chief Scientific Officer 1 pa
Board/Management Information
2014-08-24 English
Appendix 3B 10 pages 274.3KB
Capital/Financing Update
2014-08-24 English
Mayne Pharma out-licenses IP to Hedgepath Pharmaceuticals 3 pages 134.5KB
Capital/Financing Update
2014-06-24 English
Wilson HTM Companies Conference Presentation 9 pages 1.1MB
Investor Presentation
2014-06-02 English
Appendix 3B 9 pages 340.5KB
Share Issue/Capital Change
2014-05-11 English
Initial Notice - WBC 13 pages 339.4KB
Major Shareholding Notification
2014-04-09 English
Becoming a substantial holder from BTT 14 pages 173.7KB
Major Shareholding Notification
2014-04-09 English
Half Yearly Report and Accounts 33 pages 938.1KB
Interim / Quarterly Report
2014-02-25 English
2014 Half Year Media Release 5 pages 241.1KB
Interim / Quarterly Report
2014-02-25 English
2014 Half Year Investor Presentation 16 pages 911.2KB
Interim / Quarterly Report
2014-02-25 English
Appendix 3B 9 pages 222.4KB
Capital/Financing Update
2014-02-25 English
Section 708A notice 1 page 220.7KB
Capital/Financing Update
2014-02-18 English
Appendix 3B 9 pages 225.3KB
Capital/Financing Update
2014-02-18 English
Completion of placement 2 pages 109.1KB
Capital/Financing Update
2014-02-12 English
Trading Halt 2 pages 384.1KB
Capital/Financing Update
2014-02-11 English
Mayne Pharma announces acquisition of LORCET & ESGIC 3 pages 252.7KB
Capital/Financing Update
2014-02-11 English
Investor Presentation Acquisition of LORCET & ESGIC 11 pages 768.0KB
Investor Presentation
2014-02-11 English
Mayne Pharma results and product update 2 pages 221.1KB
Earnings Release
2014-02-05 English